Evaluation of a novel nanocrystalline hydroxyapatite paste Ostim® in comparison to Alpha-BSM® - more bone ingrowth inside the implanted material with Ostim® compared to Alpha BSM®

摘要

BackgroundThe purpose of this study was to evaluate the performance a newly developed nanocrystalline hydroxyapatite, OSTIM^® following functional implantation in femoral sites in thirty-eight sheep for 1, 2 or 3 months. Ostim^® 35 was compared to an established calcium phosphate, Alpha BSM^®.